NASDAQ:MRM
MEDIROM Healthcare Technologies Inc.
- Stock
Last Close
3.81
26/07 20:00
Market Cap
19.53M
Beta: 0.01
Volume Today
406
Avg: 4.48K
PE Ratio
28.23
PFCF: −4.94
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|
average inventory | 5.96M - | 6.73M 13.04% | 13.33M 97.96% | 66.41M 398.19% | ||
average payables | 131.95M - | 78.72M 40.34% | 132.88M 68.79% | 219.24M 65.00% | ||
average receivables | 708.24M - | 1.23B 73.84% | 1.27B 3.32% | 1.09B 14.32% | ||
book value per share | -24.38 - | 124.43 610.45% | 94.38 24.15% | -42.72 145.26% | ||
capex per share | -10.39 - | -4.04 61.14% | -25.87 540.68% | -23.33 9.83% | ||
capex to depreciation | -1.13 - | -0.42 62.75% | -1.67 296.35% | -0.90 46.08% | -0.90 0.37% | |
capex to operating cash flow | -0.35 - | -2.47 600.50% | 0.28 111.48% | 0.20 28.15% | 0.24 18.92% | |
capex to revenue | -0.01 - | -0.00 65.87% | -0.07 1,375.66% | -0.02 71.40% | -0.02 13.84% | |
cash per share | 50.74 - | 114.49 125.63% | 68.85 39.87% | 81.43 18.27% | ||
days of inventory on hand | 0.94 - | 0.68 27.94% | 2.64 288.70% | 1.71 35.35% | 8.24 382.43% | |
days payables outstanding | 20.83 - | 15.13 27.37% | 11.58 23.45% | 21.10 82.17% | 15.00 28.91% | |
days sales outstanding | 68.35 - | 72.25 5.70% | 435.29 502.51% | 57.71 86.74% | 69.52 20.47% | |
debt to assets | 0.63 - | 0.50 21.16% | 0.29 41.12% | 0.49 66.01% | 0.48 1.35% | |
debt to equity | -24.23 - | 3.94 116.25% | 2.34 40.54% | -13.40 672.50% | -54.42 305.97% | |
dividend yield | ||||||
earnings yield | 0.01 - | 0.00 73.51% | -0.18 8,367.50% | -0.29 61.45% | ||
enterprise value | 10.68B - | 9.78B 8.37% | 6.62B 32.32% | 5.82B 12.12% | 2.63B 54.87% | |
enterprise value over ebitda | 67.05 - | 74.93 11.75% | -7.11 109.49% | -25.51 258.95% | 7.32 128.68% | |
ev to operating cash flow | 75.26 - | 1.24K 1,551.74% | -18.07 101.45% | -10.44 42.21% | -3.83 63.33% | |
ev to sales | 3.11 - | 2.50 19.51% | 4.68 86.80% | 1.08 77.00% | 0.38 64.89% | |
free cash flow per share | 19.03 - | -2.41 112.65% | -116.91 4,758.84% | -137.58 17.67% | ||
free cash flow yield | 0.01 - | -0.00 112.82% | -0.08 5,282.80% | -0.20 150.90% | ||
graham net net | -810.67 - | -626.71 22.69% | -276.80 55.83% | -1.01K 263.94% | ||
graham number | 86.84 - | 100.32 15.52% | 754.77 652.38% | 441.84 41.46% | ||
income quality | 2.14 - | 0.45 78.78% | 0.68 49.69% | 0.56 17.24% | -4.60 918.41% | |
intangibles to total assets | 0.03 - | 0.03 5.68% | 0.04 13.33% | 0.17 363.96% | 0.14 18.88% | |
interest coverage | 4.73 - | 6.21 31.22% | -45.19 827.76% | -31.76 29.71% | 17.83 156.14% | |
interest debt per share | 593.96 - | 492.80 17.03% | 224.17 54.51% | 575.05 156.52% | ||
inventory turnover | 386.74 - | 536.66 38.77% | 138.06 74.27% | 213.57 54.69% | 44.27 79.27% | |
invested capital | -24.23 - | 3.94 116.25% | 2.34 40.54% | -13.40 672.50% | -54.42 305.97% | |
market cap | 8.04B - | 7.93B 1.32% | 5.98B 24.67% | 3.40B 43.16% | ||
net current asset value | -3.71B - | -2.78B 25.01% | -739.49M 73.39% | -4.58B 519.23% | -4.44B 2.96% | |
net debt to ebitda | 16.56 - | 14.16 14.48% | -0.69 104.89% | -10.62 1,434.14% | 7.32 168.91% | |
net income per share | 13.75 - | 3.59 73.86% | -268.26 7,562.75% | -203.13 24.28% | ||
operating cash flow per share | 29.42 - | 1.63 94.45% | -91.04 5,678.84% | -114.25 25.49% | ||
payables turnover | 17.52 - | 24.13 37.68% | 31.52 30.63% | 17.30 45.11% | 24.34 40.67% | |
receivables turnover | 5.34 - | 5.05 5.40% | 0.84 83.40% | 6.33 654.33% | 5.25 16.99% | |
research and ddevelopement to revenue | 0.01 - | |||||
return on tangible assets | 0.02 - | 0.00 75.11% | -0.37 9,885.87% | -0.21 43.56% | 0.03 112.34% | |
revenue per share | 711.90 - | 810.42 13.84% | 351.86 56.58% | 1.11K 215.23% | ||
roe | -0.56 - | 0.03 105.12% | -2.84 9,938.38% | 4.76 267.31% | -2.51 152.76% | |
roic | 0.01 - | 0.01 18.29% | -0.20 2,333.54% | -0.20 0.98% | 0.03 113.84% | |
sales general and administrative to revenue | 0.48 - | |||||
shareholders equity per share | -24.38 - | 124.43 610.45% | 94.38 24.15% | -42.72 145.26% | ||
stock based compensation to revenue | 0.00 - | 0.02 34,711.75% | 0.10 552.06% | 0.04 63.06% | ||
tangible asset value | -257.79M - | 444.14M 272.29% | 266.90M 39.91% | -1.20B 549.50% | -1.00B 16.43% | |
tangible book value per share | -53.46 - | 92.10 272.29% | 66.31 27.99% | -245.97 470.92% | ||
working capital | -1.42B - | -883.96M 37.61% | 428.34M 148.46% | -1.81B 523.54% | -1.28B 29.51% |
All numbers in USD (except ratios and percentages)